Evidence map›Paper›PMID 34615675›Full record

SynthesisBMJ open2021

Multimorbidity in South Africa: a systematic review of prevalence studies.

Rifqah Abeeda Roomaney, Brian van Wyk, Eunice Bolanle Turawa, Victoria Pillay-van Wyk

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06248190 (Effectiveness of a Health Systems Strengthening Intervention to Improve Detection, Treatment, and Control of Multiple Long-Term Conditions in Primary Health Care Facilities in the Western Cape and KwaZulu Natal, South Africa), which is not on this map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06248190 nacompletednot on this mapstarted 2023, after this paper: background citation

Effectiveness of a Health Systems Strengthening Intervention to Improve Detection, Treatment, and Control of Multiple Long-Term Conditions in Primary Health Care Facilities in the Western Cape and KwaZulu Natal, South Africa

TypeinterventionalSponsorUniversity of KwaZuluRan2023 to 2025Enrolled1,837ConditionsHIV Infections, Hypertension, Diabetes Mellitus, AsthmaArmsENHANCE intervention (health systems)
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rethinking the evidence on COVID-19 in Africa.The Lancet. Infectious diseases · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rifqah Abeeda RoomaneyBurden of Disease Research Unit, South African Medical Research Council, Cape Town, Western Cape, South Africa rifqah.roomaney@mrc.ac.za.ORCID 0000-0003-3267-8484
Brian van WykSchool of Public Health, University of the Western Cape, Cape Town, Western Cape, South Africa.ORCID 0000-0003-1032-1847
Eunice Bolanle TurawaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, Western Cape, South Africa.ORCID 0000-0003-3722-1547
Victoria Pillay-van WykBurden of Disease Research Unit, South African Medical Research Council, Cape Town, Western Cape, South Africa.ORCID 0000-0001-8772-7197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo review prevalence studies of multimorbidity in South Africa to identify prevalence estimates, common disease clusters and factors associated with multimorbidity.

designSystematic review.

settingSouth Africa (general community and healthcare facilities). DATA SOURCES: Articles were retrieved from electronic databases (PubMed, Web of Science, Scopus, CINAHL, Science Direct and JSTOR). ELIGIBILITY CRITERIA: Studies addressing the prevalence of multimorbidity in South Africa were eligible for inclusion. A systematic search was done in various databases up to December 2020. A risk of bias assessment was conducted for each article using a modified checklist. STUDY SELECTION: Two researchers independently screened titles and abstracts; assessed the risk of bias of each study and extracted data. Included studies were described using a narrative synthesis.

resultsIn total, 1407 titles were retrieved; of which 10 articles were included in the narrative synthesis. Six studies had a low risk of bias and three had a moderate risk of bias. One study was not assessed for risk of bias, because there was no criteria that apply to routine health information systems. Three of the included studies were population-based surveys, four were community-based cohorts and three cross-sectional studies of health facility data. The prevalence of multimorbidity was low to moderate (3%-23%) in studies that included younger people or had a wide range of selected age groups; and moderate to high (30%-87%) in studies of older adults. The common disease clusters were hypertension and diabetes, hypertension and HIV, and TB and HIV.

conclusionAll studies indicated that multimorbidity is a norm in South Africa, especially among older adults. Hypertension is the main driver of multimorbidity. Research on multimorbidity in South Africa needs to be strengthened with high-quality study designs. PROSPERO REGISTRATION NUMBER: CRD42020196895.

Indexed as

MultimorbidityResearch DesignAgedCross-Sectional StudiesHumansPrevalenceSouth Africaepidemiologypublic health

Identifiers

PMID34615675
PMCPMC8496399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.